129 related articles for article (PubMed ID: 27720383)
1. Impact of a combination of full coverage stenting and proximal optimization technique on long term outcome for unprotected distal left main disease.
Takagi K; Fujino Y; Naganuma T; Watanabe Y; Yabushita H; Mitomo S; Kawamoto H; Tahara S; Kobayashi T; Warisawa T; Karube K; Matsumoto T; Sato T; Ishiguro H; Kurita N; Nakamura S; Hozawa K; Nakamura S
Cardiovasc Revasc Med; 2016 Dec; 17(8):515-521. PubMed ID: 27720383
[TBL] [Abstract][Full Text] [Related]
2. Impact of gender on long-term mortality in patients with unprotected left main disease: The Milan and New-Tokyo (MITO) Registry.
Takagi K; Chieffo A; Shannon J; Naganuma T; Tahara S; Fujino Y; Latib A; Montorfano M; Carlino M; Kawamoto H; Nakamura S; Colombo A
Cardiovasc Revasc Med; 2016 Sep; 17(6):369-74. PubMed ID: 27460302
[TBL] [Abstract][Full Text] [Related]
3. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
Naganuma T; Chieffo A; Meliga E; Capodanno D; Park SJ; Onuma Y; Valgimigli M; Jegere S; Makkar RR; Palacios IF; Costopoulos C; Kim YH; Buszman PP; Chakravarty T; Sheiban I; Mehran R; Naber C; Margey R; Agnihotri A; Marra S; Capranzano P; Leon MB; Moses JW; Fajadet J; Lefevre T; Morice MC; Erglis A; Tamburino C; Alfieri O; Serruys PW; Colombo A
JACC Cardiovasc Interv; 2013 Dec; 6(12):1242-9. PubMed ID: 24355114
[TBL] [Abstract][Full Text] [Related]
5. Comparison Between 1- and 2-Stent Strategies in Unprotected Distal Left Main Disease: The Milan and New-Tokyo Registry.
Takagi K; Naganuma T; Chieffo A; Fujino Y; Latib A; Tahara S; Ishiguro H; Montorfano M; Carlino M; Kawamoto H; Kurita N; Hozawa K; Nakamura S; Nakamura S; Colombo A
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27810964
[TBL] [Abstract][Full Text] [Related]
6. Single-stent crossover technique from distal unprotected left main coronary artery to the left circumflex artery.
Naganuma T; Chieffo A; Basavarajaiah S; Takagi K; Costopoulos C; Latib A; Carlino M; Montorfano M; Bernelli C; Nakamura S; Colombo A
Catheter Cardiovasc Interv; 2013 Nov; 82(5):757-64. PubMed ID: 23674385
[TBL] [Abstract][Full Text] [Related]
7. Comparative long-term efficacy and safety of drug-eluting stent versus coronary artery bypass grafting in ostial left main coronary artery disease: analysis of the MAIN-COMPARE registry.
Lee SW; Kim SH; Kim SO; Han S; Kim YH; Park DW; Kang SJ; Lee CW; Park SW; Park SJ
Catheter Cardiovasc Interv; 2012 Aug; 80(2):206-12. PubMed ID: 22234884
[TBL] [Abstract][Full Text] [Related]
8. The DELTA 2 Registry: A Multicenter Registry Evaluating Percutaneous Coronary Intervention With New-Generation Drug-Eluting Stents in Patients With Obstructive Left Main Coronary Artery Disease.
Chieffo A; Tanaka A; Giustino G; Briede I; Sawaya FJ; Daemen J; Kawamoto H; Meliga E; D'Ascenzo F; Cerrato E; Stefanini GG; Capodanno D; Mangiameli A; Templin C; Erglis A; Morice MC; Mehran R; Van Mieghem NM; Nakamura S; De Benedictis M; Pavani M; Varbella F; Pisaniello M; Sharma SK; Tamburino C; Tchetche D; Colombo A;
JACC Cardiovasc Interv; 2017 Dec; 10(23):2401-2410. PubMed ID: 29217002
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcomes following drug-eluting stent implantation for unprotected distal trifurcation left main disease: the Milan-New Tokyo (MITO) registry.
Ielasi A; Takagi K; Latib A; Basavarajaiah S; Figini F; Carlino M; Montorfano M; Chieffo A; Nakamura S; Colombo A
Catheter Cardiovasc Interv; 2014 Mar; 83(4):530-8. PubMed ID: 23983065
[TBL] [Abstract][Full Text] [Related]
10. Immediate results and long-term clinical outcome of patients with unprotected distal left main restenosis: the CORPAL registry (Córdoba and Las Palmas).
Ojeda S; Pan M; Martín P; Mazuelos F; Suárez de Lezo J; Romero M; Segura J; Pavlovic D; Medina A; Suárez de Lezo J
JACC Cardiovasc Interv; 2014 Feb; 7(2):212-221. PubMed ID: 24440026
[TBL] [Abstract][Full Text] [Related]
11. Deployment of drug-eluting stents for isolated proximal lad disease is associated with lower major adverse cardiac events and no increase in stent thrombosis when compared with bare metal stents: a 5-year observational cohort study.
Jones DA; Rathod KS; Gallagher S; Weerackody R; Knight CJ; Rothman MT; Mathur A; Jain AK; Timmis AD; Wragg A
Catheter Cardiovasc Interv; 2013 May; 81(6):E237-44. PubMed ID: 22707383
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes following mini-crush versus culotte stenting for the treatment of unprotected left main disease: Insights from the milan and New-Tokyo (MITO) registry.
Kawamoto H; Takagi K; Chieffo A; Ruparelia N; Yusuke Fujino ; Yabushita H; Watanabe Y; Latib A; Carlino M; Montorfano M; Nakamura S; Colombo A
Catheter Cardiovasc Interv; 2017 Jan; 89(1):13-24. PubMed ID: 27471180
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
[TBL] [Abstract][Full Text] [Related]
14. Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registry.
Haiek C; Fernández-Pereira C; Santaera O; Mieres J; Rifourcat I; Lloberas J; Larribau M; Pocoví A; Rodriguez-Granillo AM; Sarmiento RA; Antoniucci D; Rodriguez AE
Catheter Cardiovasc Interv; 2017 Jan; 89(1):37-46. PubMed ID: 26947138
[TBL] [Abstract][Full Text] [Related]
15. 5-year outcomes following percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass graft for unprotected left main coronary artery lesions the Milan experience.
Chieffo A; Magni V; Latib A; Maisano F; Ielasi A; Montorfano M; Carlino M; Godino C; Ferraro M; Calori G; Alfieri O; Colombo A
JACC Cardiovasc Interv; 2010 Jun; 3(6):595-601. PubMed ID: 20630452
[TBL] [Abstract][Full Text] [Related]
16. Impact of side branch stenting on five-year long-term clinical outcome with the bifurcation-dedicated Axxess Biolimus A9-eluting stent system.
Verheye S; Buysschaert I; Grube E
EuroIntervention; 2015 Dec; 11(8):860-7. PubMed ID: 26696454
[TBL] [Abstract][Full Text] [Related]
17. Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting.
Chen SL; Chen JP; Mintz G; Xu B; Kan J; Ye F; Zhang J; Sun X; Xu Y; Jiang Q; Zhang A; Stone GW
JACC Cardiovasc Interv; 2010 Jun; 3(6):632-41. PubMed ID: 20630456
[TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcomes after unprotected left main coronary artery stenting in an all-comers patient population.
Ali M; Hanley A; McAdam B; O'Hanlon R; Gumbrielle T; Sheahan R; Foley DP
Catheter Cardiovasc Interv; 2013 Oct; 82(4):E411-8. PubMed ID: 23404813
[TBL] [Abstract][Full Text] [Related]
19. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
[TBL] [Abstract][Full Text] [Related]
20. The clinical impact of routine angiographic follow-up in randomized trials of drug-eluting stents: a critical assessment of "oculostenotic" reintervention in patients with intermediate lesions.
Uchida T; Popma J; Stone GW; Ellis SG; Turco MA; Ormiston JA; Muramatsu T; Nakamura M; Nanto S; Yokoi H; Baim DS
JACC Cardiovasc Interv; 2010 Apr; 3(4):403-11. PubMed ID: 20398868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
